1. A composition with a reduced decomposition rate and / or increased stability of its constituent components, providing reduction, softening, or even elimination of skin reactions, comprising an emulsion with an oil phase and an aqueous phase, wherein at least one anesthetic is contained in the above oil phase a compound and at least one adrenergic receptor agonist. 2. The composition of claim 1, wherein the aforementioned oil phase is a eutectic mixture of at least one anesthetic compound and at least one adrenergic receptor agonist. The composition of claim 1, wherein the aforementioned anesthetic compound is at least one local anesthetic. The composition of claim 1, wherein the aforementioned anesthetic compound is a eutectic mixture of at least two local anesthetics. The composition of claim 1, wherein the aforementioned anesthetic is selected from the group consisting of lidocaine, tetracaine, prilocaine, benzocaine, bupivacaine, mepivacaine, dibucaine, ethidocaine, butacaine, cyclomethicaine, hexylcaine, proparacaine, and lopivacaine. The composition of claim 1, wherein the aforementioned anesthetic is preferably a mixture of lidocaine and tetracaine. The composition of claim 1, wherein the aforementioned anesthetic is preferably a eutectic mixture of lidocaine and tetracaine. The composition of claim 1, wherein the aforementioned anesthetic is at least 5% based on the weight of the composition. The composition according to claim 1, in which the aforementioned anesthetic is at least 10% with respect to the weight of the composition1. Композиция с уменьшенной скоростью разложения и/или повышенной устойчивостью входящих в ее состав компонентов, обеспечивающая уменьшение или смягчение или даже устранение кожных реакций, содержащая эмульсию с масляной фазой и водной фазой, причем в вышеупомянутой масляной фазе содержится, по меньшей мере, одно анестетическое соединение и, по меньшей мере, один агонист адренергических рецепторов.2. Композиция по п.1, в которой выш
